Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial.
Levison JH, Krane D, Donelan K, Aschbrenner K, Trieu HD, Chau C, Wilson A, Oreskovic NM, Irwin K, Iezzoni LI, Xie H, Samuels R, Silverman P, Batson J, Fathi A, Gamse S, Holland S, Wolfe J, Shellenberger K, Cella E, Bird B, Skotko BG, Bartels S. Levison JH, et al. Among authors: silverman p. Contemp Clin Trials. 2023 Feb;125:107053. doi: 10.1016/j.cct.2022.107053. Epub 2022 Dec 17. Contemp Clin Trials. 2023. PMID: 36539061 Free PMC article.
COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the Pandemic.
Fung V, Levison JH, Wilson A, Cheng D, Chau C, Krane D, Trieu HD, Irwin K, Cella E, Bird B, Shellenberger K, Silverman P, Batson J, Fathi A, Gamse S, Wolfe J, Holland S, Donelan K, Samuels R, Becker JE, Freedberg KA, Reichman JL, Keller T, Tsai AC, Hsu J, Skotko BG, Bartels S. Fung V, et al. Among authors: silverman p. Adm Policy Ment Health. 2024 Jan;51(1):60-68. doi: 10.1007/s10488-023-01311-9. Epub 2023 Nov 8. Adm Policy Ment Health. 2024. PMID: 37938475 Free PMC article.
Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilities.
Levison JH, Fung V, Wilson A, Cheng D, Donelan K, Oreskovic NM, Samuels R, Silverman P, Batson J, Fathi A, Gamse S, Holland S, Becker JE, Freedberg KA, Iezzoni LI, Donohue A, Viron M, Lubarsky C, Keller T, Reichman JL, Bastien B, Ryan E, Tsai AC, Hsu J, Chau C, Krane D, Trieu HD, Wolfe J, Shellenberger K, Cella E, Bird B, Bartels S, Skotko BG. Levison JH, et al. Among authors: silverman p. Disabil Health J. 2024 Oct;17(4):101645. doi: 10.1016/j.dhjo.2024.101645. Epub 2024 Jun 5. Disabil Health J. 2024. PMID: 38879412 Free article.
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108.
Stearns V, ONeill A, Schneider BP, Skaar TC, Liu MC, Lohrisch C, Goetz MP, Vallejos CS, Sparano JA, Villa D, Silverman P, Cheema PS, Moore DF Jr, Sledge GW Jr. Stearns V, et al. Among authors: silverman p. Breast Cancer Res Treat. 2024 Oct 21. doi: 10.1007/s10549-024-07519-z. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39432161
Incontinence as a catatonic sign.
Carroll BT, Honaker L, Lazzara J, Schindler E, Silverman P, Slavnic B, Theibert H, Zwiebel S, Vellanki KD. Carroll BT, et al. Among authors: silverman p. Ann Clin Psychiatry. 2022 Nov;34(4):227-232. doi: 10.12788/acp.0080. Ann Clin Psychiatry. 2022. PMID: 36282604 Review.
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
Khan SA, Zhao F, Goldstein LJ, Cella D, Basik M, Golshan M, Julian TB, Pockaj BA, Lee CA, Razaq W, Sparano JA, Babiera GV, Dy IA, Jain S, Silverman P, Fisher CS, Tevaarwerk AJ, Wagner LI, Sledge GW. Khan SA, et al. Among authors: silverman p. J Clin Oncol. 2022 Mar 20;40(9):978-987. doi: 10.1200/JCO.21.02006. Epub 2022 Jan 7. J Clin Oncol. 2022. PMID: 34995128 Free PMC article. Clinical Trial.
Biosimilar strategic implementation at a large health system.
Kar I, Kronz M, Kolychev E, Silverman P, Mendiratta P, Tomlinson BKN, Prunty J, Copley M, Patel S, Caudill S, Farah L, Wesolowski B, Crissinger T, Kendig C, Szymczak E, Duraj L, Dumot J, Acheson E, Lyamkin S, King M, Mocilnikar A, Cunningham K, Paulic N, Botzki U, Lerman R, Strosaker R, Osborne S, Glotzbecker B. Kar I, et al. Among authors: silverman p. Am J Health Syst Pharm. 2022 Feb 8;79(4):268-275. doi: 10.1093/ajhp/zxab410. Am J Health Syst Pharm. 2022. PMID: 34752608
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.
Moy B, Oliveira M, Saura C, Gradishar W, Kim SB, Brufsky A, Hurvitz SA, Ryvo L, Fagnani D, Kalmadi S, Silverman P, Delaloge S, Alarcon J, Kwong A, Lee KS, Ang PCS, Ow SGW, Chu SC, Bryce R, Keyvanjah K, Bebchuk J, Zhang B, Oestreicher N, Bose R, Chan N. Moy B, et al. Among authors: silverman p. Breast Cancer Res Treat. 2021 Jul;188(2):449-458. doi: 10.1007/s10549-021-06217-4. Epub 2021 Apr 28. Breast Cancer Res Treat. 2021. PMID: 33909203 Free PMC article. Clinical Trial.
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.
Lim B, Potter DA, Salkeni MA, Silverman P, Haddad TC, Forget F, Awada A, Canon JL, Danso M, Lortholary A, Bourgeois H, Tan-Chiu E, Vincent S, Bahamon B, Galinsky KJ, Patel C, Neuwirth R, Leonard EJ, Diamond JR. Lim B, et al. Among authors: silverman p. Clin Cancer Res. 2021 Jun 15;27(12):3329-3338. doi: 10.1158/1078-0432.CCR-20-4131. Epub 2021 Apr 5. Clin Cancer Res. 2021. PMID: 33820779
524 results